Download ARM's 2017 Industry Update slides and view the full webcast of the 7th Annual Cell & Gene Therapies State of the Industry Briefing held on January 9, 2017 in San Francisco.

ARM'S Q3 2016 QUARTERLY DATA REPORT DETAILS INDUSTRY-SPECIFIC STATISTICS COMPILED FROM MORE THAN 730 LEADING GENE THERAPY, CELL THERAPY AND OTHER REGENERATIVE MEDICINE COMPANIES WORLDWIDE. 

 

REGISTRATION IS OPEN FOR ARM'S 7TH ANNUAL ADVANCED THERAPIES SUMMMIT BEING HELD IN BARCELONA, SPAIN ON MARCH 22, 2O17. THIS MEETING IS A MUTLI-STAKEHOLDER, INTERACTIVE FORUM THAT SEEKS TO ADVANCE THE ATMP SECTOR IN EUROPE. THIS YEAR'S PROGRAM WILL FEATURE IN-DEPTH ROUNDTABLE DISCUSSIONS AND EXTENSIVE NETWORKING OPPORTUNITIES WITH LEADERS IN THE FIELD.

About ARM

Advancing Regenerative Medicine
The Alliance for Regenerative Medicine (ARM) is a Washington, DC-based multi-stakeholder advocacy organization that promotes legislative, regulatory and reimbursement initiatives necessary to facilitate access to life-giving advances in regenerative medicine. ARM also works to increase public understanding of the field and its potential to transform human healthcare, providing business development and investor outreach services to support the growth of its member companies and research organizations.
Learn more

Our Members

200+ and Growing
ARM’s membership is diverse, representing leading regenerative medicine companies and investors, university-based and non-profit research institutions, patient advocacy groups, pharmaceutical companies engaged in regenerative medicine research and other organizations supporting regenerative medicine.
Learn more